Related Experiment Video
Updated: Mar 26, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Signaling lansdscape of prostate cancer
Abstract:
Research over the decades has gradually and sequentially shown that both intratumor heterogeneity and multifocality make prostate cancer difficult to target. Different challenges associated with generation of risk-stratification tools that correlate genomic landscape with clinical outcomes severely influence clinical efficacy of therapeutic strategies. Androgen receptor mediated signaling has gained great appreciation and rewiring of AR induced signaling cascade in absence of androgen, structural variants of AR have provided near complete resolution of genomic landscape and underlying mechanisms of prostate cancer. In this review we have attempted to provide an overview of most recent advancements in our knowledge related to different signaling cascades including TGF, SHH, Notch, JAK-STAT in prostate cancer progression and development.
Insights
Prostate cancer's complexity, driven by intratumor heterogeneity and multifocality, poses treatment challenges. This review details recent advancements in understanding signaling pathways crucial for prostate cancer progression.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Intratumor heterogeneity and multifocality complicate prostate cancer targeting.
- Developing effective risk-stratification tools is hindered by challenges in correlating genomic data with clinical outcomes.
- Androgen receptor (AR) signaling plays a critical role in prostate cancer, with its rewiring and structural variants offering insights into disease mechanisms.
Purpose of the Study:
- To provide an overview of recent advancements in understanding prostate cancer signaling pathways.
- To highlight the role of various signaling cascades in prostate cancer development and progression.
Main Methods:
- Literature review of recent research on prostate cancer signaling.
- Analysis of studies focusing on intratumor heterogeneity, genomic landscape, and AR signaling.
- Examination of signaling pathways including TGF, SHH, Notch, and JAK-STAT.
Main Results:
- Androgen receptor (AR) mediated signaling and its rewiring are central to prostate cancer.
- Structural variants of AR have significantly improved the understanding of the prostate cancer genomic landscape.
- Multiple signaling cascades, including TGF, SHH, Notch, and JAK-STAT, are implicated in prostate cancer progression.
Conclusions:
- Understanding the complex signaling networks is crucial for developing targeted therapies for prostate cancer.
- Recent advancements in genomic analysis and signaling pathway research offer new avenues for therapeutic strategies.
- Further research into these pathways can lead to improved risk stratification and clinical efficacy.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
mTOR Signaling and Cancer Progression
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Hedgehog Signaling Pathway
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...

